MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma

European Journal of Cancer

Volumn 46, Issue 12, 2010, Pages 2285-2294

  Sasahira, Tomonori ^a   Kirita, Tadaaki ^a   Kurihara, Miyako ^a   Yamamoto, Kazuhiko ^a   Bhawal, Ujjal K ^a   Bosserhoff, Anja Katrin ^b   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Angiogenesis; Lymphangiogenesis; MIA; OSCC; VEGF; VEGF C; VEGF D

Indexed keywords

FORMALDEHYDE; MELANOMA INHIBITORY ACTIVITY PROTEIN; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TONGUE SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TONGUE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77955709708     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.04.027     Document Type: Article

References (47)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2 2001 153 156
2. S. Tanaka, and T. Sobue Comparison of oral and pharyngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000) Jpn J Clin Oncol 35 8 2005 488 491
3. T. Sasahira, T. Kirita, and U.K. Bhawal Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma Histopathology 51 2 2007 166 172
4. T. Sasahira, T. Kirita, and N. Oue High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma Cancer Sci 99 9 2008 1806 1812
5. P.P. Dos Reis, R.R. Bharadwaj, and J. Machado Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma Cancer 113 11 2008 3169 3180
6. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 7070 2005 932 936
7. R.H. Adams, and K. Alitalo Molecular regulation of angiogenesis and lymphangiogenesis Nat Rev Mol Cell Biol 8 6 2007 464 478
8. C.J. Avraamides, B. Garmy-Susini, and J.A. Varner Integrins in angiogenesis and lymphangiogenesis Nat Rev Cancer 8 8 2008 604 617
9. T. Nakazato, S. Shingaki, and N. Kitamura Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity Oncol Rep 15 4 2006 825 830
10. S. Bierer, E. Herrmann, and T. Kopke Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma Oncol Rep 20 4 2008 721 725
11. J.A. Nagy, E. Vasile, and D. Feng Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis J Exp Med 196 11 2002 1497 1506
12. S. Hirakawa, S. Kodama, and R. Kunstfeld VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis J Exp Med 201 7 2005 1089 1099
13. G.D. Yancopoulos, S. Davis, and N.W. Gale Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
14. T. Veikkola, and K. Alitalo VEGFs, receptors and angiogenesis Semin Cancer Biol 9 1999 211 220
15. M. Skobe, T. Hawighorst, and D.G. Jackson Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nat Med 7 2001 192 198
16. M. Lohela, M. Bry, T. Tammela, and K. Alitalo VEGFs and receptors involved in angiogenesis versus lymphangiogenesis Curr Opin Cell Biol 21 2009 154 165
17. S.C. Campbell, O.V. Volpert, M. Ivanovich, and N.P. Bouck Molecular mediators of angiogenesis in bladder cancer Cancer Res 58 6 1998 1298 1304
18. L. Santos, C. Costa, and S. Pereira Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours Ann Oncol 14 9 2003 1419 1424
19. M. Moriyama, S. Kumagai, and S. Kawashiri Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma Oral Oncol 33 5 1997 369 374
20. H. Nakaya, S. Kawashiri, and A. Tanaka Influences of angiogenesis and lymphangiogenesis on cancerous invasion in experimentally induced tongue carcinoma J Oral Pathol Med 34 2 2005 87 92
21. K.L. Dumoff, C. Chu, and X. Xu Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix Mod Pathol 18 1 2005 97 104
22. F. Renyi-Vamos, J. Tovari, and J. Fillinger Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer Clin Cancer Res 11 20 2005 7344 7353
23. T. Nomiya, K. Nemoto, E. Nakata, Y. Takai, and S. Yamada Expression of thymidine phosphorylase and VEGF in esophageal squamous cell carcinoma Oncol Rep 15 6 2006 1497 1501
24. T. Donnem, K. Al-Shibli, and S. Al-Saad VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells Lung cancer 63 2 2009 277 283
25. M.J. Currie, V. Hanrahan, and S.P. Gunningham Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas J Clin Pathol 57 8 2004 829 834
26. M. Miyahara, J. Tanuma, K. Sugihara, and I. Semba Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma Cancer 110 6 2007 1287 1294
27. T. Sasahira, T. Kirita, and U.K. Bhawal The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma Virchows Arch 450 3 2007 287 295
28. A. Blesch, A.K. Bosserhoff, and R. Apfel Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA Cancer Res 54 1994 5695 5701
29. A.K. Bosserhoff, R. Stoll, and J.P. Sleeman Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity Lab Invest 83 11 2003 1583 1594
30. R. Bauer, M. Humphries, and R. Fassler Regulation of integrin activity by MIA J Biol Chem 281 17 2006 11669 11677
31. P. Jachimczak, R. Apfel, and A.K. Bosserhoff Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques Int J Cancer 113 2005 88 92
32. D.C. Allred, J.M. Harvey, M. Berardo, and G.M. Clark Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 2 1998 155 168
33. K. Maeda, Y.S. Chung, and Y. Ogawa Prognostic value of vascular endothelial growth factor expression in gastric carcinoma Cancer 77 5 1996 858 863
34. Y. Takahashi, Y. Kitadai, C.D. Bucana, K.R. Cleary, and L.M. Ellis Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer Cancer Res 55 18 1995 3964 3968
35. T. Dietrich, J. Onderka, and F. Bock Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade Am J Pathol 171 1 2007 361 372
36. Z. Liu, K. Kobayashi, and M. van Dinther VEGF and inhibitors of TGF{beta} type-I receptor kinase synergistically promote blood-vessel formation by inducing {alpha}5-integrin expression J Cell Sci 122 Pt 18 2009 3294 3302
37. C. Treins, S. Giorgetti-Peraldi, J. Murdaca, and E. Van Obberghen Regulation of vascular endothelial growth factor expression by advanced glycation end products J Biol Chem 276 47 2001 43836 43841
38. S. Kobayashi, T. Kishimoto, and S. Kamata Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis Cancer Sci 98 5 2007 726 733
39. R.K. Jain, L.L. Munn, and D. Fukumura Dissecting tumour pathophysiology using intravital microscopy Nat Rev Cancer 2 4 2002 266 276
40. R.T. Tong, Y. Boucher, and S.V. Kozin Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors Cancer Res 64 11 2004 3731 3736
41. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 5706 2005 58 62
42. T.P. Padera, B.R. Stoll, and J.B. Tooredman Pathology: cancer cells compress intratumour vessels Nature 427 6976 2004 695
43. T.P. Padera, A. Kadambi, and E. di Tomaso Lymphatic metastasis in the absence of functional intratumor lymphatics Science 296 5574 2002 1883 1886
44. K. Shimizu, H. Kubo, and K. Yamaguchi Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer Cancer Sci 95 4 2004 328 333
45. M. Kodama, Y. Kitadai, and M. Tanaka Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms Clin Cancer Res 14 22 2008 7205 7214
46. Y.K. Hong, B. Lange-Asschenfeldt, and P. Velasco VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins FASEB J 18 10 2004 1111 1113
47. C. Cursiefen, L. Chen, and L.P. Borges VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment J Clin Invest 113 7 2004 1040 1050